University of Illinois at Chicago
Announcement of an Exempt Purchase
Vendor: Guerbet, Bloomington, IN
Amount: An estimated $600,000
An estimated start date of 7/11/2018 through 7/10/2023
The University award process may be delayed up to thirty days as this award goes through a state approval process.
First published Thursday, July 12, 2018
The University awarded a contract for Lipiodol.
Lipiodol is combined with chemotherapeutic agents and then injected into the hepatic artery to treat hepatocellular carcinoma.
This purchase is exempt from the usual selection processes of the Procurement Code because the procurement expenditure is for medical supplies or medical services necessary for the delivery of care and treatment at medical, dental, or veterinary teaching facilities utilized by SIU or U of I (30 ILCS 500 / 1-13(b-5)) If the University of Illinois Hospital is not able to purchase Lipiodol, the Hospital will not be able to provide this life-saving therapy and patients will have to be referred to other centers resulting in treatment delays and negative patient outcomes.
For additional information, contact:
The State of Illinois has a policy to encourage prospective vendors to hire
qualified veterans, minorities, females, persons with disabilities and ex-offenders.